Cleanroom Pressure Loss During a Storm: Releasing TPN and Heparin Flushes
At 2 a.m. a winter storm knocks out a hospital's emergency generator for four hours. The IV cleanroom's temperature rises to 78°F and the antechamber pressure gauge no longer shows positive pressure to the buffer area. The night pharmacist has six patient-specific TPN bags due at 6 a.m., prepared before the outage, and 20 heparin-flush syringes prepared the previous evening with a 24-hour beyond-use date. The pharmacy's written policy says to discard CSPs when environmental limits are exceeded, but the nursing supervisor says the TPN will be late and asks the pharmacist to release the bags because "they are in sealed containers." The hospital is due for a Board inspection next month.
1. May the pharmacist release the TPN bags and heparin flushes?
Read the worked answer
No. USP <797> relies on controlled temperature and a maintained pressure cascade to assure sterility. If the cleanroom exceeded its temperature limits and lost positive pressure to the buffer area for hours, the environment can no longer be assumed to be in a validated state, and sterility assurance for CSPs prepared or exposed during the excursion is compromised. Sealed containers do not cure a failed environment or a lost pressure cascade. The TPN bags and syringes should be quarantined and, under the pharmacy's own policy, discarded unless a documented scientific risk assessment and environmental monitoring support retention-which is generally not feasible for patient-specific CSPs after a four-hour loss of control. The pharmacist should arrange replacement TPN and tell nursing the product cannot be released.
2. What assessment, documentation, and corrective action should follow?
Read the worked answer
Notify the pharmacy director or PIC and infection prevention. Document the start and end times, temperature readings, pressure readings, which CSPs were exposed, and who made the release decision. Perform environmental monitoring-nonviable particle counts, viable sampling, and pressure checks-and have the HVAC and generator serviced before compounding resumes. Conduct a root-cause review: generator testing, alarms, backup power, temperature and pressure alarms, and staff training. The night pharmacist should not be pressured into releasing product; the decision belongs to the quality program and the PIC, and a contemporaneous deviation record protects both patients and the hospital. The corrective action plan should be written and tracked to completion.
3. What will a Board inspector expect to see, and what are the compliance risks?
Read the worked answer
The inspector will ask for temperature and pressure logs, environmental monitoring results, SOPs, training and qualification records, deviation and CAPA records, and the identity of the person who authorized any release. Missing, incomplete, or back-filled logs are serious findings because they undermine the claim that the cleanroom was in a validated state. The hospital should produce contemporaneous documentation, show that affected CSPs were quarantined, and explain the corrective action. Releasing CSPs after a known excursion is a patient-safety and licensure risk. If the hospital also ships compounded preparations to another state, separate nonresident pharmacy licensure questions arise and should be reviewed before any shipment.